Related Experiment Video
Updated: Jul 29, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population
Said Chaaban1,2, Andrea Zimmer3, Vijaya Raj Bhatt4
1VA Nebraska Western Iowa Health Care System, Omaha, NE 68105, USA.
Bacterial pneumonias are a common complication in patients with chronic graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. This review focuses on specific bacterial pathogens causing pneumonia in this vulnerable patient population.
Area of Science:
- Hematology
- Immunology
- Infectious Diseases
Background:
- Allogeneic stem cell transplantation (SCT) is a critical therapy for hematologic malignancies.
- Post-transplant complications include graft-versus-host disease (GVHD) and immune deficiency, increasing infection risk.
- Bacterial infections are the most frequent cause of morbidity in SCT patients.
Purpose of the Study:
- To review bacterial pathogens causing pneumonia in patients with chronic GVHD.
- To highlight the specific infectious risks in this immunocompromised population.
Main Methods:
- Literature review of bacterial pneumonias in chronic GVHD patients post-SCT.
Main Results:
- Bacterial infections are a leading cause of morbidity and mortality in SCT recipients.
- Patients with chronic GVHD are particularly susceptible to specific bacterial pneumonias.
Conclusions:
- Understanding the spectrum of bacterial pathogens is crucial for managing pneumonia in chronic GVHD patients.
- Targeted prevention and treatment strategies are needed to reduce infectious complications.
More Related Videos
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
01:29Pneumonia II: Pathophysiology
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...